Breaking News Instant updates and real-time market news.

2022-11-30 20:49:37 IRAA Iris Acquisition $10.02 / +0.005 (+0.05%) 20:49 11/30/22 11/30 20:49 11/30/22 20:49	Iris Acquisition to combine with Liminatus Pharma Liminatus Pharma and Iris Acquisition Corp "announced they have entered into a definitive business combination agreement. Upon closing of the transaction, the combined company will be renamed "Liminatus Pharma, Inc.". The combined company's common stock is expected to be listed on the Nasdaq Capital Market. The transaction funding includes commitments for a $15M common stock PIPE financing and a $25M convertible note financing to further support Liminatus' business growth strategy. The business combination implies a pro forma enterprise value of the combined company of approximately $334 million. The combined company is expected to receive gross cash proceeds of up to $316M, comprising the $276 million held in Iris' trust account and a concurrent, committed $15 million equity PIPE financing of common stock issued at $10.00 per share and $25M convertible note financing with an initial conversion rate of $11.50 per share of common stock, subject to future adjustments based upon the price of Iris' publicly traded common stock. The combined company will bear deferred underwriting commissions and transaction expenses out of the gross proceeds."

2022-11-30 20:49:37

IRAA

Iris Acquisition

$10.02 / +0.005 (+0.05%)

20:49

11/30/22

11/30

20:49

11/30/22

20:49

Iris Acquisition to combine with Liminatus Pharma

Liminatus Pharma and Iris Acquisition Corp "announced they have entered into a definitive business combination agreement. Upon closing of the transaction, the combined company will be renamed "Liminatus Pharma, Inc.". The combined company's common stock is expected to be listed on the Nasdaq Capital Market. The transaction funding includes commitments for a $15M common stock PIPE financing and a $25M convertible note financing to further support Liminatus' business growth strategy. The business combination implies a pro forma enterprise value of the combined company of approximately $334 million. The combined company is expected to receive gross cash proceeds of up to $316M, comprising the $276 million held in Iris' trust account and a concurrent, committed $15 million equity PIPE financing of common stock issued at $10.00 per share and $25M convertible note financing with an initial conversion rate of $11.50 per share of common stock, subject to future adjustments based upon the price of Iris' publicly traded common stock. The combined company will bear deferred underwriting commissions and transaction expenses out of the gross proceeds."

OTHER BREAKING NEWS FROM THE FLY

Downgrade	Bath & Body Works downgraded to Neutral at UBS on softlines bearishness » 08:38 03/29/23 03/29 08:38 03/29/23 08:38 BBWI Bath & Body Works $38.05 / +1.375 (+3.75%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options BBWI Bath & Body Works $38.05 / +1.375 (+3.75%) 03/06/23 Bath & Body Works announces appointment of Kuhn to board of directors 02/27/23 Bath & Body Works calls Third Point's potential proxy contest 'misguided' 02/23/23 Bath & Body Works taking enterprise-wide effort to reduce expenses 02/23/23 Bath & Body Works responds to Third Point intent to nominate board candidates BBWI Bath & Body Works $38.05 / +1.375 (+3.75%) 06:19 Today UBS Bath & Body Works downgraded to Neutral from Buy at UBS 03/23/23 Piper Sandler Bath & Body Works price target lowered to $48 from $52 at Piper Sandler 03/17/23 Argus Bath & Body Works cut to Hold at Argus on online competition, slowing sales 03/17/23 Argus Bath & Body Works downgraded to Hold from Buy at Argus BBWI Bath & Body Works $38.05 / +1.375 (+3.75%) 02/23/23 Bath & Body Works sees FY23 cont ops EPS $2.50-$3.00, consensus $3.16 02/23/23 Bath & Body Works sees Q1 cont ops EPS 17c-27c, consensus 44c 02/23/23 Bath & Body Works reports Q4 cont ops EPS $1.86, consensus $1.62 02/22/23 Notable companies reporting before tomorrow's open BBWI Bath & Body Works $38.05 / +1.375 (+3.75%) 02/22/23 Third Point plans proxy fight at Bath & Body Works, WSJ reports 02/22/23 Third Point plans proxy fight at Bath & Body Works, WSJ reports BBWI Bath & Body Works $38.05 / +1.375 (+3.75%) 03/17/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/23/23 Fly Intel: Pre-market Movers 02/22/23 What You Missed On Wall Street On Wednesday 02/15/23 What You Missed On Wall Street On Wednesday BBWI Bath & Body Works $38.05 / +1.375 (+3.75%) 03/28/23 Early notable gainers among liquid option names on March 28th 03/22/23 Early notable gainers among liquid option names on March 22nd 02/16/23 Bath & Body Works call volume above normal and directionally bullish 02/01/23 Bath & Body Works call volume above normal and directionally bullish
Initiation	Inspire Medical initiated with a Buy at UBS » 08:38 03/29/23 03/29 08:38 03/29/23 08:38 INSP Inspire Medical $238.42 / -9.82 (-3.96%) In a sector note on U.S.… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events INSP Inspire Medical $238.42 / -9.82 (-3.96%) 03/21/23 Inspire Medical announces FDA approval for pediatric patients with Down Syndrome 03/09/23 Inspire Medical receives countrywide reimbursement approval in Belgium 12/20/22 Inspire Medical publishes inaugural ESG summary report INSP Inspire Medical $238.42 / -9.82 (-3.96%) 03/28/23 UBS Inspire Medical initiated with a Buy at UBS 02/08/23 Lake Street Inspire Medical price target raised to $305 from $250 at Lake Street 02/08/23 Truist Inspire Medical price target raised to $330 from $310 at Truist 02/08/23 Piper Sandler Inspire Medical price target raised to $305 from $300 at Piper Sandler INSP Inspire Medical $238.42 / -9.82 (-3.96%) 02/07/23 Inspire Medical reports Q4 EPS 10c, consensus (57c) 01/09/23 Inspire Medical sees FY22 revenue $407.5M-$407.9M, consensus $387.61M 01/09/23 Inspire Medical sees Q4 revenue $137.5M-$137.9M, consensus $117.03M 11/01/22 Inspire Medical raises FY22 revenue view to $384M-$388M from $354M-$362M 12 Aug INSP Inspire Medical $238.42 / -9.82 (-3.96%) 01/31/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/27/23 Inspire Medical Systems, Inc.
Recommendations	Biomea Fusion price target raised to $47 from $25 at Oppenheimer » 08:38 03/29/23 03/29 08:38 03/29/23 08:38 BMEA Biomea Fusion $30.74 / +15.27 (+98.71%) Oppenheimer raised the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options BMEA Biomea Fusion $30.74 / +15.27 (+98.71%) 03/28/23 Biomea Fusion trading resumes 03/28/23 Biomea Fusion trading halted, volatility trading pause 03/28/23 Biomea Fusion announces data from ongoing Phase II study of BMF-219 01/17/23 Biomea Fusion doses first patient in COVALENT-102 trial of BMF-219 BMEA Biomea Fusion $30.74 / +15.27 (+98.71%) 06:06 Today Citi Biomea Fusion price target raised to $60 from $20 at Citi 03/28/23 H.C. Wainwright Biomea Fusion price target raised to $44 from $37 at H.C. Wainwright 03/28/23 Piper Sandler Biomea Fusion price target raised to $40 from $16 at Piper Sandler 02/24/23 Citi Biomea Fusion initiated with a Buy at Citi BMEA Biomea Fusion $30.74 / +15.27 (+98.71%) 03/28/23 Biomea Fusion reports Q4 EPS (21c), consensus (81c) 11/07/22 Biomea Fusion reports Q3 EPS (78c), consensus (65c) 30 Mar BMEA Biomea Fusion $30.74 / +15.27 (+98.71%) 03/28/23 What You Missed On Wall Street On Tuesday 03/28/23 What You Missed On Wall Street This Morning BMEA Biomea Fusion $30.74 / +15.27 (+98.71%) 03/28/23 Biomea Fusion options imply 11.3% move in share price post-earnings
Earnings	Cintas reports Q4 EPS $3.14, consensus $3.04 » 08:37 03/29/23 03/29 08:37 03/29/23 08:37 CTAS Cintas $443.89 / +3.48 (+0.79%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events CTAS Cintas $443.89 / +3.48 (+0.79%) 12/16/22 Cintas launches electric vehicle pilot program 11/15/22 Cintas expands cleanroom footprint with new facility in New York CTAS Cintas $443.89 / +3.48 (+0.79%) 12/22/22 Wells Fargo Cintas price target raised to $450 from $393 at Wells Fargo 12/22/22 Deutsche Bank Cintas price target raised to $507 from $490 at Deutsche Bank 12/22/22 Baird Cintas price target raised to $500 from $475 at Baird 12/22/22 Morgan Stanley Cintas price target raised to $401 from $373 at Morgan Stanley CTAS Cintas $443.89 / +3.48 (+0.79%) 12/21/22 Cintas raises FY23 EPS view to $12.50-$12.80 from $12.30-$12.65 12/21/22 Cintas reports Q2 EPS $3.12, consensus $3.03 CTAS Cintas $443.89 / +3.48 (+0.79%) 12/21/22 What You Missed On Wall Street On Wednesday 12/21/22 What You Missed On Wall Street This Morning 10:00 Today Cintas - CTAS
Hot Stocks	Taoping enters long-term strategic cooperation agreement with Zhaoyuan City » 08:37 03/29/23 03/29 08:37 03/29/23 08:37 TAOP Taoping / + Taoping has entered into… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News TAOP Taoping / + 03/17/23 Taoping receives Nasdaq minimum bid price requirement extension 11/17/22 Taoping signs three-year strategic cooperation agreement with ZhongShengShi Co. 11/09/22 Taoping signs three-year cooperation agreement with DoWatch Technology 10/18/22 Taoping enters into strategic cooperation with Jiangsu SuLiXin
Hot Stocks	BK Technologies receives $781K order for KNG Series mobile radios » 08:37 03/29/23 03/29 08:37 03/29/23 08:37 BKTI BK Technologies $2.98 / -0.15 (-4.79%) BK Technologies received… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings BKTI BK Technologies $2.98 / -0.15 (-4.79%) 03/16/23 BK Technologies board decides to suspend quarterly cash dividend 03/09/23 BK Technologies receives purchase order for InteropONE PTToC service 03/08/23 WidePoint signs reseller agreement with BK Technologies 03/08/23 BK Technologies signs reseller agreement with WidePoint BKTI BK Technologies $2.98 / -0.15 (-4.79%) 09/19/22 ThinkEquity BK Technologies initiated with a Buy at ThinkEquity BKTI BK Technologies $2.98 / -0.15 (-4.79%) 03/16/23 BK Technologies reports Q4 EPS (6c) vs. (2c) last year 11/03/22 BK Technologies reports Q3 EPS (14c) vs. (15c) last year
Initiation	Boston Scientific initiated with a Buy at UBS » 08:36 03/29/23 03/29 08:36 03/29/23 08:36 BSX Boston Scientific $48.60 / +0.265 (+0.55%) In a sector note on U.S.… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options BSX Boston Scientific $48.60 / +0.265 (+0.55%) 01/11/23 Boston Scientific targeting 'double digit' EPS growth in 2023, consensus $1.93 12/11/22 Fly Intel: Top five weekend stock stories 12/11/22 Boston Scientific to acquire majority stake of Acotec Scientific 11/29/22 Apollo Endosurgery to be acquired by Boston Scientific for $10.00 per share BSX Boston Scientific $48.60 / +0.265 (+0.55%) 03/28/23 UBS Boston Scientific initiated with a Buy at UBS 03/08/23 Wells Fargo Wells downgrades Edwards Lifesciences with Medtronic gaining share 02/17/23 Argus Boston Scientific price target raised to $55 from $50 at Argus 02/02/23 Needham Boston Scientific price target raised to $53 from $48 at Needham BSX Boston Scientific $48.60 / +0.265 (+0.55%) 02/01/23 Boston Scientific sees FY23 adjusted EPS $1.86-$1.93, consensus $1.93 02/01/23 Boston Scientific sees Q1 adjusted EPS 42c-44c, consensus 44c 02/01/23 Boston Scientific reports Q4 adjusted EPS 45c, consensus 47c 01/31/23 Notable companies reporting before tomorrow's open BSX Boston Scientific $48.60 / +0.265 (+0.55%) 12/22/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/29/22 What You Missed On Wall Street On Tuesday 11/29/22 What You Missed On Wall Street This Morning 10/26/22 What You Missed On Wall Street This Morning 05/04/23 Boston Scientific Corporation BSX Boston Scientific $48.60 / +0.265 (+0.55%) 01/11/23 Boston Scientific put volume heavy and directionally bearish
Hot Stocks	CytoSorbents announces study on CytoSorb hemoperfusion » 08:36 03/29/23 03/29 08:36 03/29/23 08:36 CTSO CytoSorbents $3.39 / +0.055 (+1.65%) CytoSorbents highlights… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CTSO CytoSorbents $3.39 / +0.055 (+1.65%) 03/22/23 CytoSorbents highlights new data to prevent endothelial damage to blood vessels 03/14/23 CytoSorbents reports no direct exposure to SVB, Signature Bank 03/07/23 CytoSorbents announces new European guidelines that consider hemoadsorption 01/23/23 CytoSorbents' STAR-T trial receives Health Canada regulatory approval CTSO CytoSorbents $3.39 / +0.055 (+1.65%) 05/04/22 B. Riley CytoSorbents price target lowered to $6 from $7 at B. Riley CTSO CytoSorbents $3.39 / +0.055 (+1.65%) 03/09/23 CytoSorbents reports Q4 revenue $9.4M, consensus $8.72M 01/31/23 CytoSorbents sees Q4 revenue $9.4M, consensus $8.9M 11/03/22 CytoSorbents reports Q3 EPS (28c), consensus (16c)
Hot Stocks	Foretell Reality partners with UMD Robert H. Smith School of Business » 08:36 03/29/23 03/29 08:36 03/29/23 08:36 VRAR Glimpse Group $3.64 / -0.04 (-1.09%) The Glimpse Group… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Options VRAR Glimpse Group $3.64 / -0.04 (-1.09%) 03/22/23 QReal enters contractto develop AR experience for Denny's 02/27/23 Brightline Interactive signs CRADA with U.S. NSWCDD 02/21/23 PulpoAR announces Fingernail Segmentation, Skin Diagnostics integration 02/09/23 Glimpse Israel selected by Israeli Ministry of Education as key partner VRAR Glimpse Group $3.64 / -0.04 (-1.09%) 12/19/22 EF Hutton Glimpse Group assumed with a Buy at EF Hutton VRAR Glimpse Group $3.64 / -0.04 (-1.09%) 02/14/23 Glimpse Group options imply 13.9% move in share price post-earnings
Earnings	Paychex reports Q3 EPS $1.29, consensus $1.24 » 08:36 03/29/23 03/29 08:36 03/29/23 08:36 PAYX Paychex $108.88 / -0.1 (-0.09%) Reports Q3 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events PAYX Paychex $108.88 / -0.1 (-0.09%) 01/24/23 Paychex appoints Theresa Payton to Board of Directors 12/28/22 Paychex VP Gioja sells $1.6M in company shares 12/11/22 Fly Intel: Top five weekend stock stories 10/14/22 Paychex names President and CEO John Gibson, Jr. to board PAYX Paychex $108.88 / -0.1 (-0.09%) 03/13/23 Barclays Paychex price target lowered to $105 from $110 at Barclays 01/17/23 Barclays Paychex downgraded to Underweight from Equal Weight at Barclays 01/03/23 Deutsche Bank Paychex price target lowered to $116 from $123 at Deutsche Bank 12/27/22 Evercore ISI Paychex price target lowered to $114 from $117 at Evercore ISI PAYX Paychex $108.88 / -0.1 (-0.09%) 03/28/23 Notable companies reporting before tomorrow's open 03/28/23 Notable companies reporting before tomorrow's open 12/22/22 Paychex raises FY23 adjusted EPS view to up 12%-14% from up 11%-12% 12/22/22 Paychex reports Q2 adjusted EPS 99c, consensus 95c PAYX Paychex $108.88 / -0.1 (-0.09%) 12/10/22 Microsoft, Arista among stocks that can survive a triple whammy, Barron's says PAYX Paychex $108.88 / -0.1 (-0.09%) 12/23/22 What You Missed On Wall Street On Friday 12/23/22 What You Missed On Wall Street This Morning 12/22/22 What You Missed On Wall Street On Thursday 12/22/22 What You Missed On Wall Street This Morning 09:30 Today Paychex - PAYX

Initiation	Craig-Hallum bullish on Gambling.com, initiates with a Buy » 08:35 03/29/23 03/29 08:35 03/29/23 08:35 GAMB Gambling.com $9.51 / -0.22 (-2.26%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options GAMB Gambling.com $9.51 / -0.22 (-2.26%) 03/08/23 Gambling.com ready to launch online sports betting in MA with BetMassachusetts 02/08/23 Gannett sees strategic partnership with Gambling.com as immediately accretive GAMB Gambling.com $9.51 / -0.22 (-2.26%) 07:20 Today Craig-Hallum Gambling.com initiated with a Buy at Craig-Hallum 11/18/22 Stifel Gambling.com price target raised to $12 at Stifel after 'solid' Q3 10/25/22 Truist Gambling.com price target raised to $12 from $10.50 at Truist 08/30/22 Truist Gambling.com price target lowered to $10.50 from $12 at Truist GAMB Gambling.com $9.51 / -0.22 (-2.26%) 03/23/23 Gambling.com reports Q4 adjusted EPS 2c, consensus 2c 11/17/22 Gambling.com backs FY22 revenue $71M-$76M, consensus $71M 11/17/22 Gambling.com reports Q3 adjusted EPS 16c, two estimates 5c GAMB Gambling.com $9.51 / -0.22 (-2.26%) 03/24/23 Bet On It: New York weekly wagering numbers see March Madness bump 11/17/22 Fly Intel: After-Hours Movers GAMB Gambling.com $9.51 / -0.22 (-2.26%) 10/19/22 Twelve new option listings and two option delistings on October 19th
Initiation	Insulet initiated with a Neutral at UBS » 08:35 03/29/23 03/29 08:35 03/29/23 08:35 PODD Insulet $311.43 / -3.26 (-1.04%) In a sector note on U.S.… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly PODD Insulet $311.43 / -3.26 (-1.04%) 03/15/23 Insulet to replace SVB Financial in S&P 500 at open on 3/15 03/10/23 Insulet to replace SVB Financial in S&P 500 at open on 3/15 03/10/23 Insulet to replace SVB Financial in S&P 500 02/14/23 Insulet acquires assets of Automated Glucose Control for $25M PODD Insulet $311.43 / -3.26 (-1.04%) 03/28/23 UBS Insulet initiated with a Neutral at UBS 02/24/23 Raymond James Insulet price target raised to $334 from $320 at Raymond James 02/24/23 Baird Insulet price target raised to $350 from $340 at Baird 02/24/23 Barclays Insulet price target raised to $292 from $245 at Barclays PODD Insulet $311.43 / -3.26 (-1.04%) 02/23/23 Insulet sees FY23 revenue growth 14%-19%, consensus $1.47B 02/23/23 Insulet sees Q1 revenue growth 11%-14%, consensus $333.86M 02/23/23 Insulet reports Q4 adjusted EPS 55c, consensus 21c 11/03/22 Insulet raises FY22 revenue growth view to 18%-19% from 14%-17% PODD Insulet $311.43 / -3.26 (-1.04%) 02/22/23 Apple hits breakthroughs in glucose monitoring project, Bloomberg reports PODD Insulet $311.43 / -3.26 (-1.04%) 02/23/23 Fly Intel: After-Hours Movers 02/22/23 Diabetes management stocks slide on report of tech giant's breakthroughs 10/18/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Earnings	IM Cannabis reports Q4 EPS ($1.28) vs. (19c) last year » 08:34 03/29/23 03/29 08:34 03/29/23 08:34 IMCC IM Cannabis / + Reports Q4 continuing… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research IMCC IM Cannabis / + 10/12/22 Avant Brands, IM Cannabis launch BLKMKT in Israel 10/12/22 Avant Brands, IM Cannabis announce the launch of BLK MKT in Israel IMCC IM Cannabis / + 08/16/22 Alliance Global Partners IM Cannabis price target lowered to $1.50 from $6 at Alliance Global Partners
Hot Stocks	Global Tech Industries updates shareholders on contact with FINRA » 08:34 03/29/23 03/29 08:34 03/29/23 08:34 GTII Global Tech Industries $2.32 / +0.085 (+3.80%) Global Tech Industries… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News GTII Global Tech Industries $2.32 / +0.085 (+3.80%) 02/24/23 Creatd terminates discussions with Global Tech on proposed acquisition 01/23/23 Global Tech appoints Donald Gilbert to lead illegal trading task force 01/10/23 Global Tech Industries executes binding LOI for Creatd acquisition 12/06/22 Global Tech retains ShareIntel-Shareholder to assist Christian Levine Law
Hot Stocks	Nikola says has received orders for 100 Class 8 FCEVs » 08:34 03/29/23 03/29 08:34 03/29/23 08:34 NKLA Nikola $1.48 / -0.045 (-2.96%) Nikola announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NKLA Nikola $1.48 / -0.045 (-2.96%) 03/27/23 Nikola CFO Kim Brady to retire, Anastasiya Pasterick to succeed 03/16/23 Nikola says battery manufacturing move to Arizona ahead of schedule 02/23/23 Nikola provides 2023 outlook 02/22/23 Nikola, E.ON and Richter Group sign collaboration agreement NKLA Nikola $1.48 / -0.045 (-2.96%) 03/13/23 Morgan Stanley Nikola initiated with an Equal Weight at Morgan Stanley 02/24/23 Deutsche Bank Nikola price target lowered to $3 from $5 at Deutsche Bank 02/24/23 Cowen Nikola price target lowered to $5 from $10 at Cowen 01/17/23 BTIG Nikola price target lowered to $5 from $7 at BTIG NKLA Nikola $1.48 / -0.045 (-2.96%) 02/23/23 Nikola reports Q4 adjusted EPS (37c), consensus (43c) 02/22/23 Notable companies reporting before tomorrow's open 02/22/23 Notable companies reporting before tomorrow's open 11/03/22 Nikola reports Q3 adjusted EPS (28c), consensus (39c) NKLA Nikola $1.48 / -0.045 (-2.96%) 01/20/23 Nikola speculated by The Deal as 'attractive' to activist 12/01/22 Fuzzy Panda short Fisker, says 'asset-light' model really 'liability-heavy' 10/14/22 Nikola founder Milton found guilty in criminal fraud trial, Bloomberg says 10/14/22 Jury reaches verdict in Nikola founder criminal fraud trial, Bloomberg says NKLA Nikola $1.48 / -0.045 (-2.96%) 03/13/23 What You Missed On Wall Street On Monday 03/13/23 What You Missed On Wall Street This Morning 03/13/23 What You Missed This Week in EVs and Clean Energy 03/13/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations NKLA Nikola $1.48 / -0.045 (-2.96%) 03/21/23 Largest borrow rate increases among liquid names 03/15/23 Largest borrow rate increases among liquid names 03/08/23 Notable open interest changes for March 8th 02/03/23 Largest borrow rate increases among liquid names
Hot Stocks	KULR Technology appoints Shawn Canter as new FO » 08:34 03/29/23 03/29 08:34 03/29/23 08:34 KULR KULR Technology / + , GS Goldman Sachs $318.50 / -0.09 (-0.03%) KULR Technology (KULR)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options KULR GS KULR KULR Technology / + 03/13/23 KULR Technology opens research and development center in Texas 02/07/23 KULR announces issuance of U.S. patent covering Li-Ion battery storage 02/01/23 KULR Technology retains Integrous Communications 01/23/23 KULR Technology CEO says 'time to stand up to naked short selling' GS Goldman Sachs $318.50 / -0.09 (-0.03%) 03/28/23 Apple introduces Apple Pay Later, consumers able to pay for purchases over time 03/26/23 Fly Intel: Top five weekend stock stories 03/24/23 Ally Financial names Russell Hutchinson as CFO, effective July 3 03/19/23 Fly Intel: Top five weekend stock stories KULR GS KULR KULR Technology / + GS Goldman Sachs $318.50 / -0.09 (-0.03%) 03/24/23 RBC Capital Goldman Sachs price target lowered to $339 from $370 at RBC Capital 03/09/23 BofA Goldman Sachs price target raised to $425 from $384 at BofA 03/02/23 Seaport Global Goldman remains a top pick at Seaport after investor day 03/01/23 Jefferies Jefferies keeps Buy on Goldman Sachs, says 'questions remain' after investor day KULR GS KULR KULR Technology / + 03/23/23 KULR Technology reports Q4 EPS (4c), consensus (5c) GS Goldman Sachs $318.50 / -0.09 (-0.03%) 01/17/23 Goldman Sachs reports Q4 EPS $3.32, consensus $5.48 10/18/22 Goldman Sachs reports Q3 EPS $8.25, consensus $7.69 10/17/22 Notable companies reporting before tomorrow's open 10/17/22 Notable companies reporting before tomorrow's open GS GS Goldman Sachs $318.50 / -0.09 (-0.03%) 03/26/23 Banking stress puts U.S., Europe on watch for credit crunch, Reuters says 03/20/23 Goldman tells Reuters Credit Suisse AT1 move could cut long-term demand 03/20/23 Big-bank CEOs discussing capital infusion for First Republic, WSJ says 03/18/23 Biggest banks looking like winners, Barron's says GS GS Goldman Sachs $318.50 / -0.09 (-0.03%) 03/16/23 What You Missed On Wall Street This Morning 02/24/23 What You Missed On Wall Street On Friday 02/17/23 What You Missed On Wall Street On Friday 02/17/23 What You Missed On Wall Street This Morning 04/18/23 Goldman Sachs - GS 04/26/23 Goldman Sachs Group Inc. GS GS Goldman Sachs $318.50 / -0.09 (-0.03%) 03/09/23 World Low Volatility ETF put volume heavy and directionally bearish 01/17/23 Unusually active option classes on open January 17th 12/05/22 World Low Volatility ETF put volume heavy and directionally bearish 10/18/22 Unusually active option classes on open October 18th
Initiation	Tandem Diabetes initiated with a Neutral at UBS » 08:33 03/29/23 03/29 08:33 03/29/23 08:33 TNDM TNDM / + In a sector note on U.S.… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly TNDM TNDM / + 03/20/23 S&P announces changes to S&P 400, 600 indices at open on 3/20 03/15/23 Tandem Diabetes announces NEJM publication of study on t:slim X2 insulin pump 03/03/23 S&P announces changes to S&P 400, 600 indices at open on 3/20 02/22/23 Tandem Diabetes names Rebecca Robertson as new board chair TNDM TNDM / + 03/28/23 UBS Tandem Diabetes initiated with a Neutral at UBS 03/07/23 Lake Street Tandem pairing with Abbott sensors can be 'big deal,' says Lake Street 02/23/23 Craig-Hallum Tandem Diabetes price target lowered to $74 from $80 at Craig-Hallum 02/23/23 Piper Sandler Tandem Diabetes price target lowered to $50 from $70 at Piper Sandler TNDM TNDM / + 02/22/23 Tandem Diabetes sees FY23 revenue $885M-$900M, consensus $891.6M 02/22/23 Tandem Diabetes reports Q4 EPS (25c), consensus (6c) 02/22/23 Notable companies reporting after market close 01/10/23 Tandem Diabetes sees FY22 revenue at 'approximately' $805M, consensus $802.5M TNDM TNDM / + 02/22/23 Apple hits breakthroughs in glucose monitoring project, Bloomberg reports TNDM TNDM / + 02/22/23 Fly Intel: After-Hours Movers 02/22/23 Diabetes management stocks slide on report of tech giant's breakthroughs 01/11/23 What You Missed On Wall Street On Wednesday 01/11/23 What You Missed On Wall Street This Morning
Hot Stocks	ProMIS Neurosciences presents in vitro preclinical data on PMN310 » 08:33 03/29/23 03/29 08:33 03/29/23 08:33 PMN ProMIS Neurosciences $4.30 / + (+0.00%) ProMIS Neurosciences… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News PMN ProMIS Neurosciences $4.30 / + (+0.00%) 10/12/22 ProMIS Neurosciences closes $7.4M private placement
Recommendations	Restructuring not positive for growth companies like Lucid, says BofA » 08:33 03/29/23 03/29 08:33 03/29/23 08:33 LCID Lucid Group $7.56 / -0.58 (-7.13%) After Lucid announced a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options LCID Lucid Group $7.56 / -0.58 (-7.13%) 07:33 Today Lucid Group to cut workforce by about 18% as part of restructuring plan 03/28/23 Lucid Group down 6% to $7.64 following report of layoffs 03/27/23 Lucid recalls 2022-2023 Lucid Air vehicles for issue with electric motors 02/22/23 Lucid Group down 8% afterhours at $9.14 after Q4 results and 2023 outlook LCID Lucid Group $7.56 / -0.58 (-7.13%) 08:22 Today Morgan Stanley Other EV startups may need to consider actions like Lucid, says Morgan Stanley 03/02/23 Citi Lucid Group price target lowered to $11.50 from $12 at Citi 02/23/23 R.F. Lafferty Lucid Group price target lowered to $12 from $17 at R.F. Lafferty 02/23/23 Exane BNP Paribas Lucid Group downgraded to Neutral from Outperform at Exane BNP Paribas LCID Lucid Group $7.56 / -0.58 (-7.13%) 02/22/23 Lucid Group reports Q4 EPS (28c), consensus (40c) 02/22/23 Notable companies reporting after market close 11/08/22 Lucid Group reports Q3 EPS (40c), consensus (31c) 11/08/22 Notable companies reporting after market close LCID Lucid Group $7.56 / -0.58 (-7.13%) 03/28/23 Lucid Group to eliminate 18% of workforce, Insider reports 01/30/23 Fuzzy Panda short Lucid Group, calls buyout rumor 'fake news' 01/30/23 Fuzzy Panda says sell Lucid Group on 'fake' buyout rumor 01/27/23 Lucid Group spike attributed to takeout speculation by Betaville LCID Lucid Group $7.56 / -0.58 (-7.13%) 03/28/23 What You Missed On Wall Street On Tuesday 02/27/23 What You Missed This Week in EVs and Clean Energy 02/23/23 What You Missed On Wall Street On Thursday 02/23/23 What You Missed On Wall Street This Morning 04/24/23 Lucid Group Inc LCID Lucid Group $7.56 / -0.58 (-7.13%) 03/21/23 Largest borrow rate increases among liquid names 02/28/23 Largest borrow rate increases among liquid names 02/27/23 Largest borrow rate increases among liquid names 02/22/23 Lucid Group options imply 13.9% move in share price post-earnings
Hot Stocks	CVS Health completes acquisition of Signify Health » 08:33 03/29/23 03/29 08:33 03/29/23 08:33 CVS CVS Health $73.13 / -0.41 (-0.56%) , SGFY Signify Health $30.50 / +0.025 (+0.08%) Under the terms of the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CVS SGFY CVS CVS Health $73.13 / -0.41 (-0.56%) 03/27/23 CVS Health expects to complete Signify Health acquisition around March 29 03/14/23 Senate Democrats urge Walmart, Kroger, others to sell mifepristone 03/06/23 Oscar Health announces renewed agreement with CVS Caremark 02/08/23 CVS Health says Oak Street Health deal has long term growth, earnings power SGFY Signify Health $30.50 / +0.025 (+0.08%) 03/27/23 CVS Health expects to complete Signify Health acquisition around March 29 03/06/23 Cardinal Health, Signify Health collaborate on in-home health management 02/13/23 Soros Fund buys Horizon Therapeutics, exits BNY Mellon in Q4 01/11/23 Signify Health announces collaboration with Prospect Medical CVS SGFY CVS CVS Health $73.13 / -0.41 (-0.56%) 03/21/23 Wolfe Research Oak Street Health downgraded to Peer Perform from Outperform at Wolfe Research 03/15/23 TD Cowen Oak Street Health downgraded to Market Perform from Outperform at TD Cowen 02/15/23 Bernstein Oak Street Health downgraded to Market Perform from Outperform at Bernstein 02/10/23 Raymond James Oak Street Health downgraded to Market Perform from Outperform at Raymond James SGFY Signify Health $30.50 / +0.025 (+0.08%) 11/02/22 B. Riley B. Riley downgrades Semler Scientific on risk from Signify buyout 09/20/22 Piper Sandler Change Healthcare downgraded to Neutral from Overweight at Piper Sandler 09/12/22 William Blair Option Care a 'must-own' in smidcap healthcare services, says William Blair 09/07/22 Evercore ISI CVS Health price target raised to $125 from $120 at Evercore ISI CVS SGFY CVS CVS Health $73.13 / -0.41 (-0.56%) 02/08/23 CVS Health sees FY23 revenue $332.7B-$338.5B, consensus $325.11B 02/08/23 CVS Health reports Q4 adjusted EPS $1.99, consensus $1.92 02/08/23 CVS Health sees FY24 adjusted EPS $9.00, FY25 adjusted EPS $10.00 02/08/23 CVS Health backs FY23 adjusted EPS view $8.70-$8.90, consensus $8.86 SGFY Signify Health $30.50 / +0.025 (+0.08%) 01/10/23 CVS Health reaffirms FY23 adjusted EPS view $8.70-$8.90, consensus $8.86 CVS CVS CVS Health $73.13 / -0.41 (-0.56%) 03/08/23 Walgreens stops offer abortion pill in 21 states, face blowback, NYTimes report 02/06/23 CVS Health near deal to acquire Oak Street Health for $10.5B, WSJ says 02/06/23 CVS Health near deal to acquire Oak Street Health for $10.5B, WSJ says 01/27/23 Cigna sues CVS Health, Amy Bricker for violating noncompete, Bloomberg Law says CVS SGFY CVS CVS Health $73.13 / -0.41 (-0.56%) 02/24/23 Sell these stocks now, proven algorithm says 02/08/23 What You Missed On Wall Street On Wednesday 02/08/23 What You Missed On Wall Street This Morning 02/08/23 Fly Intel: Pre-market Movers SGFY Signify Health $30.50 / +0.025 (+0.08%) 02/24/23 Sell these stocks now, proven algorithm says 11/02/22 Semler sinks after results as analyst highlights risk from Signify buyout 04/24/23 RSA Conference 2023 05/03/23 CVS Health - CVS CVS CVS CVS Health $73.13 / -0.41 (-0.56%) 03/15/23 CVS Health put volume heavy and directionally bearish 03/06/23 Unusually active option classes on open March 6th 02/08/23 Early notable gainers among liquid option names on February 8th 02/08/23 Unusually active option classes on open February 8th

Hot Stocks	Aquestive Therapeutics expands license, supply agreement with Pharmanovia » 08:32 03/29/23 03/29 08:32 03/29/23 08:32 AQST Aquestive Therapeutics / + Aquestive Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings AQST Aquestive Therapeutics / + 01/06/23 Aquestive Therapeutics provides business update, 2023 objectives 12/22/22 Aquestive Therapeutics completes FDA End-of-Phase 2 meeting for AQST-109 11/29/22 Aquestive Therapeutics announces publication of crossover food effect study 10/27/22 Aquestive licenses Sympazan Oral Film to Assertio AQST Aquestive Therapeutics / + 03/09/23 Wedbush Aquestive Therapeutics upgraded at Wedbush with cash runway extended 03/09/23 Wedbush Aquestive Therapeutics upgraded to Outperform from Neutral at Wedbush 01/31/23 Wedbush Aquestive Therapeutics downgraded to Neutral from Outperform at Wedbush 11/04/22 Alliance Global Partners Aquestive price target lowered to $7 from $10 at Alliance Global Partners AQST Aquestive Therapeutics / + 03/07/23 Aquestive Therapeutics sees FY23 revenue $37M-$41M, consensus $37.83M 03/07/23 Aquestive Therapeutics reports Q4 EPS (23c), consensus (23c)
Hot Stocks	VirnetX enters non-exclusive sales agreement with Solution Synergy » 08:31 03/29/23 03/29 08:31 03/29/23 08:31 VHC VirnetX $1.71 / +0.03 (+1.79%) VirnetX announced that it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Options	Eleven new option listings and one option delisting on March 29th » 08:30 03/29/23 03/29 08:30 03/29/23 08:30 AESI Atlas Energy $16.61 / +0.07 (+0.42%) , BFS Saul Centers $37.26 / -0.07 (-0.19%) , BHB Bar Harbor Bankshares $25.91 / -0.955 (-3.56%) , BMRC Bank of Marin $23.00 / -0.635 (-2.69%) , CCBG Capital City Bank $30.07 / -0.57 (-1.86%) , CHCT Community Healthcare $35.16 / -0.01 (-0.03%) , EQBK Equity Bancshares $24.35 / -0.565 (-2.27%) , FMBH First Mid-Illinois Bancshares $27.17 / -0.155 (-0.57%) , IESC IES Holdings $43.60 / +0.605 (+1.41%) , MOFG MidWestOne $24.00 / -0.07 (-0.29%) , MPB Mid Penn Bancorp $25.68 / -0.04 (-0.16%) , SIVB SVB Financial / + New option listings for… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options AESI CHCT FMBH IESC MOFG MPB SIVB AESI Atlas Energy $16.61 / +0.07 (+0.42%) 03/15/23 Atlas Energy founder buys $5.04M in common stock CHCT Community Healthcare $35.16 / -0.01 (-0.03%) 03/03/23 Community Healthcare announces passing of chairman, CEO Wallace 02/13/23 Community Healthcare CEO Timothy Wallace to take medical leave 02/09/23 Community Healthcare raises quarterly dividend 0.25c to 44.75c per share 10/27/22 Community Healthcare increased common stock cash dividend to 44.5c per share FMBH First Mid-Illinois Bancshares $27.17 / -0.155 (-0.57%) 03/21/23 First Mid Bancshares to acquire Blackhawk Bancorp for $90.3M IESC IES Holdings $43.60 / +0.605 (+1.41%) 02/03/23 IES Holdings sees higher cash tax rate for 2023 vs. 2022 02/03/23 IES Holdings 'optimistic' about long-term fundamentals in 'key markets' 12/06/22 IES board authorizes $40M share repurchase program 10/10/22 IES Holdings divests STR Mechanical to SkyKnight Capital affiliate MOFG MidWestOne $24.00 / -0.07 (-0.29%) 11/29/22 MidWestOne CEO buys $857K in common stock 10/19/22 MidWestOne appoints Charles Reeves as CEO MPB Mid Penn Bancorp $25.68 / -0.04 (-0.16%) 12/20/22 Mid Penn Bancorp to acquire Brunswick Bancorp in $53.9M cash, stock transaction SIVB SVB Financial / + 03/27/23 FDIC investigating misconduct in management of SVB Financial, Signature Bank 03/27/23 First Citizens 'encouraged' by SVB's strong underwriting 03/27/23 First Citizens: Capital ratios remains robust after SVB pact 03/27/23 First Citizens acquires deposits and loans of Silicon Valley Bank AESI BFS BHB BMRC CCBG CHCT EQBK FMBH IESC MOFG MPB SIVB AESI Atlas Energy $16.61 / +0.07 (+0.42%) BFS Saul Centers $37.26 / -0.07 (-0.19%) 03/09/23 B. Riley Saul Centers price target lowered to $42 from $47 at B. Riley 01/04/23 Raymond James Saul Centers downgraded to Market Perform from Outperform at Raymond James 11/21/22 B. Riley Saul Centers price target lowered to $47 from $53 at B. Riley 08/09/22 B. Riley Saul Centers downgraded to Neutral on valuation at B. Riley BHB Bar Harbor Bankshares $25.91 / -0.955 (-3.56%) 12/12/22 Keefe Bruyette Bar Harbor Bankshares downgraded to Market Perform from Outperform at Keefe Bruyette BMRC Bank of Marin $23.00 / -0.635 (-2.69%) 03/02/23 Janney Montgomery Scott Janney upgrades Bank of Marin to Buy, sees opportunity for near-term catalyst 03/02/23 Janney Montgomery Scott Bank of Marin upgraded to Buy from Neutral at Janney Montgomery Scott CCBG Capital City Bank $30.07 / -0.57 (-1.86%) 04/26/22 Piper Sandler Capital City Bank upgraded to Overweight from Neutral at Piper Sandler CHCT Community Healthcare $35.16 / -0.01 (-0.03%) 02/16/23 Baird Community Healthcare price target raised to $43 from $38 at Baird 01/17/23 Truist Community Healthcare price target raised to $48 from $43 at Truist 01/17/23 Piper Sandler Community Healthcare price target raised to $45 from $41 at Piper Sandler 01/13/23 Janney Montgomery Scott Community Healthcare upgraded to Buy at Janney amid REIT rating rebalancing EQBK Equity Bancshares $24.35 / -0.565 (-2.27%) 06/17/22 Piper Sandler Equity Bancshares price target lowered to $35 from $38 at Piper Sandler FMBH First Mid-Illinois Bancshares $27.17 / -0.155 (-0.57%) 07/07/22 Raymond James First Mid-Illinois Bancshares upgraded to Outperform from Market Perform at Raymond James 07/07/22 Raymond James First Mid-Illinois Bancshares upgraded to Outperform from Market Perform at Raymond James IESC IES Holdings $43.60 / +0.605 (+1.41%) MOFG MidWestOne $24.00 / -0.07 (-0.29%) 12/12/22 Keefe Bruyette MidWestOne downgraded to Market Perform from Outperform at Keefe Bruyette MPB Mid Penn Bancorp $25.68 / -0.04 (-0.16%) 02/09/23 Stephens Stephens raises Mid Penn Bancorp price target to $38 following Q4 results SIVB SVB Financial / + 08:29 Today RBC Capital Sunrun price target lowered to $34 from $42 at RBC Capital 03/28/23 DA Davidson First Citizens price target raised to $1,025 from $825 at DA Davidson 03/24/23 Morgan Stanley nCino price target lowered to $27 from $35 at Morgan Stanley 03/23/23 Raymond James Block short report doesn't include 'bombshell,' says Raymond James BFS BHB BMRC CCBG CHCT EQBK FMBH IESC MOFG SIVB BFS Saul Centers $37.26 / -0.07 (-0.19%) 03/02/23 Saul Centers reports Q4 FFO 72c, consensus 73c BHB Bar Harbor Bankshares $25.91 / -0.955 (-3.56%) 01/19/23 Bar Harbor Bankshares reports Q4 EPS 83c vs. 65c last year BMRC Bank of Marin $23.00 / -0.635 (-2.69%) 01/23/23 Bank of Marin reports Q4 EPS 81c, consensus 80c 10/24/22 Bank of Marin reports Q3 EPS 76c, consensus 74c CCBG Capital City Bank $30.07 / -0.57 (-1.86%) 01/24/23 Capital City Bank reports Q4 EPS 68c, consensus 74c 10/25/22 Capital City Bank reports Q3 EPS 67c, consensus 66c CHCT Community Healthcare $35.16 / -0.01 (-0.03%) 02/14/23 Community Healthcare reports Q4 AFFO 63c, consensus 60c 11/01/22 Community Healthcare Trust reports Q3 AFFO 63c, consensus 59c EQBK Equity Bancshares $24.35 / -0.565 (-2.27%) 01/25/23 Equity Bancshares reports Q4 EPS 72c, consensus 80c 10/18/22 Equity Bancshares reports Q3 EPS 93c, consensus 80c FMBH First Mid-Illinois Bancshares $27.17 / -0.155 (-0.57%) 01/26/23 First Mid-Illinois Bancshares reports Q4 EPS $1.01, consensus 94c 10/27/22 First Mid-Illinois Bancshares reports Q3 adjusted EPS 90c, consensus 94c IESC IES Holdings $43.60 / +0.605 (+1.41%) 02/03/23 IES Holdings reports Q1 adjusted EPS 82c vs. 83c last year 12/06/22 IES Holdings reports Q4 adjusted EPS 95c vs. $1.30 last year MOFG MidWestOne $24.00 / -0.07 (-0.29%) 01/26/23 Correction: MidWestOne reports Q4 EPS $1.02, consensus $1.09 10/27/22 MidWestOne reports Q3 EPS $1.17, consensus $1.01 SIVB SVB Financial / + 03/10/23 Compugen considers exposure to SVB Financial as immaterial 01/19/23 SVB Financial reports Q4 EPS $4.62, consensus $5.27 10/20/22 SVB Financial reports Q3 EPS $7.21, consensus $6.95 10 Mar 09 Mar SIVB SIVB SVB Financial / + 03/27/23 First Republic interest may have cooled SVB auction, CNBC reports 03/24/23 Citizens Financial working on bid for SVB Private, Reuters reports 03/24/23 JPMorgan managed to gain most customers who fled SVB, NY Post reports. 03/22/23 SVB Financial accuses FDIC of 'improer actions,' Reuters reports AESI BMRC SIVB AESI Atlas Energy $16.61 / +0.07 (+0.42%) 03/11/23 Opening Day: Atlas Energy raises $324M in 2023's second biggest IPO BMRC Bank of Marin $23.00 / -0.635 (-2.69%) 03/02/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/23/23 What You Missed On Wall Street On Monday 01/23/23 What You Missed On Wall Street This Morning 10/24/22 What You Missed On Wall Street On Monday SIVB SVB Financial / + 03/27/23 What You Missed On Wall Street On Monday 03/27/23 What You Missed On Wall Street This Morning 03/27/23 Fly Intel: Pre-market Movers 03/24/23 What You Missed On Wall Street On Friday 04/25/23 Capital City Bank Group 04/25/23 Mid Penn Bancorp Inc 04/25/23 Equity Bancshares, Inc. 04/26/23 First Mid Bancshares Inc. 04/27/23 MidWestOne Financial Group, Inc. 05/04/23 Community Healthcare Trust, Inc. 05/09/23 Mid Penn Bancorp Inc SIVB SIVB SVB Financial / + 02/02/23 Early notable gainers among liquid option names on February 2nd 01/20/23 Early notable gainers among liquid option names on January 20th 01/19/23 SVB Capital II options imply 7.1% move in share price post-earnings 12/29/22 Early notable gainers among liquid option names on December 29th
Recommendations	Sunrun price target lowered to $34 from $42 at RBC Capital » 08:29 03/29/23 03/29 08:29 03/29/23 08:29 RUN Sunrun $17.55 / -0.3 (-1.68%) , SIVB SVB Financial / + , CS Credit Suisse / + RBC Capital lowered the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options RUN SIVB CS RUN Sunrun $17.55 / -0.3 (-1.68%) 03/10/23 Sunrun says has less than $80M of cash deposits with SVB 02/23/23 Sunrun sees FY23 installed growth up 10%-15% 02/22/23 Chanos says still short Sunrun 02/06/23 Sunrun, PG&E collaborate on battery-powered virtual power plant SIVB SVB Financial / + 03/27/23 FDIC investigating misconduct in management of SVB Financial, Signature Bank 03/27/23 First Citizens 'encouraged' by SVB's strong underwriting 03/27/23 First Citizens: Capital ratios remains robust after SVB pact 03/27/23 First Citizens acquires deposits and loans of Silicon Valley Bank CS Credit Suisse / + 05:43 Today UBS board names Sergio Ermotti as new group CEO, effective April 5 03/27/23 Invesco Mortgage says no direct counterparty exposure to Credit Suisse 03/21/23 Chubb says does not have exposure to any Credit Suisse AT1 bonds 03/20/23 S&P revises UBS Group outlook to Negative, affirms ratings RUN SIVB CS RUN Sunrun $17.55 / -0.3 (-1.68%) 03/10/23 GLJ Research Sunrun has lost two largest lenders in 90 days, says GLJ Research 03/09/23 Citi Sunrun initiated with a Neutral at Citi 03/02/23 Scotiabank Sunrun initiated with an Outperform at Scotiabank 02/24/23 Deutsche Bank Sunrun price target lowered to $33 from $36 at Deutsche Bank SIVB SVB Financial / + 03/28/23 DA Davidson First Citizens price target raised to $1,025 from $825 at DA Davidson 03/24/23 Morgan Stanley nCino price target lowered to $27 from $35 at Morgan Stanley 03/23/23 Raymond James Block short report doesn't include 'bombshell,' says Raymond James 03/22/23 BofA Regional bank distress gives CME Group a new growth opportunity, says BofA CS Credit Suisse / + 03/24/23 Jefferies UBS downgraded to Hold from Buy at Jefferies 03/20/23 Barclays European Banks sector view downgraded to Neutral at Barclays 03/20/23 Societe Generale UBS downgraded to Hold from Buy at Societe Generale 03/20/23 BofA UBS upgraded to Buy from Neutral at BofA RUN SIVB CS RUN Sunrun $17.55 / -0.3 (-1.68%) 02/22/23 Sunrun reports Q4 GAAP EPS 29c, consensus (5c) 02/22/23 Notable companies reporting after market close 11/02/22 Sunrun sees Net Subscriber Value increasing sequentially in Q4 from Q3 11/02/22 Sunrun reports Q3 diluted EPS 96c, may not compare to consensus (9c) SIVB SVB Financial / + 03/10/23 Compugen considers exposure to SVB Financial as immaterial 01/19/23 SVB Financial reports Q4 EPS $4.62, consensus $5.27 10/20/22 SVB Financial reports Q3 EPS $7.21, consensus $6.95 CS Credit Suisse / + 02/09/23 Credit Suisse reports Q4 net revenue CHF 3.06B vs. CHF 4.58B last year 10/27/22 Credit Suisse reports Q3 net revenue CHF 3.8B vs. CHF 5.43B last year 10 Mar SIVB CS SIVB SVB Financial / + 03/27/23 First Republic interest may have cooled SVB auction, CNBC reports 03/24/23 Citizens Financial working on bid for SVB Private, Reuters reports 03/24/23 JPMorgan managed to gain most customers who fled SVB, NY Post reports. 03/22/23 SVB Financial accuses FDIC of 'improer actions,' Reuters reports CS Credit Suisse / + 07:27 Today Credit Suisse 'never lived up to 2014 U.S. plea agreement,' CNBC's Javers says 03/26/23 Banking stress puts U.S., Europe on watch for credit crunch, Reuters says 03/26/23 Regulator says Credit Suisse could face disciplinary action, Reuters reports 03/24/23 Deutsche Bank default insurance reaches four-year high, Reuters reports RUN SIVB CS RUN Sunrun $17.55 / -0.3 (-1.68%) 03/24/23 Sell these stocks now, proven algorithm says 03/13/23 What You Missed This Week in EVs and Clean Energy 03/03/23 Sell these stocks now, proven algorithm says 02/24/23 Sell these stocks now, proven algorithm says SIVB SVB Financial / + 03/27/23 What You Missed On Wall Street On Monday 03/27/23 What You Missed On Wall Street This Morning 03/27/23 Fly Intel: Pre-market Movers 03/24/23 What You Missed On Wall Street On Friday CS Credit Suisse / + 03/24/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/21/23 What You Missed On Wall Street This Morning 03/20/23 What You Missed On Wall Street On Monday 03/20/23 What You Missed On Wall Street This Morning RUN SIVB CS RUN Sunrun $17.55 / -0.3 (-1.68%) 03/24/23 Sunrun put volume heavy and directionally bearish 03/17/23 Sunrun put volume heavy and directionally bearish 03/10/23 Sunrun call volume above normal and directionally bullish 02/22/23 Sunrun options imply 10.5% move in share price post-earnings SIVB SVB Financial / + 02/02/23 Early notable gainers among liquid option names on February 2nd 01/20/23 Early notable gainers among liquid option names on January 20th 01/19/23 SVB Capital II options imply 7.1% move in share price post-earnings 12/29/22 Early notable gainers among liquid option names on December 29th CS Credit Suisse / + 03/20/23 Notable open interest changes for March 20th 03/17/23 Notable open interest changes for March 17th 03/17/23 Largest borrow rate increases among liquid names 03/16/23 Unusually active option classes on open March 16th
Hot Stocks	Southern Michigan Bancorp increases quarterly dividend to 14c per share » 08:27 03/29/23 03/29 08:27 03/29/23 08:27 SOMC Southern Michigan Bancorp $18.61 / + (+0.00%) The Board of Directors of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Earnings SOMC Southern Michigan Bancorp $18.61 / + (+0.00%) 02/15/23 Southern Michigan Bancorp reports Q4 EPS 79c vs. 56c last year 10/26/22 Southern Michigan Bancorp reports Q3 EPS 79c vs. 69c last year

Events

Earnings calls, analyst events, roadshows and more

BOSC
Today at 09:00

BOS Better Online Solutions - BOSC Conference Calls
IBEX
Today at 09:00

Ibex - IBEX Conference Calls
UNF
Today at 09:00

UniFirst - UNF Conference Calls
RDW
Today at 09:00

Redwire - RDW Conference Calls
CLH
Today at 09:00

Clean Harbors Firm Sponsored Meetings

Virtual Meeting
PAYX
Today at 09:30

Paychex - PAYX Conference Calls
RMR
Today at 09:30

The RMR Group Inc. Firm Sponsored Meetings
Today at 10:00

Pending Home Sales Index: February 2023 Government Event
Today at 10:00

State Street Investor Confidence Index: March 2023 Government Event
Today at 10:00

Joint Committee Meeting Government Event

Teleconference

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	YGF X YGF YanGuFang IPO Managers: EF Hutton Priced at: $4.00 2M Shares ZJYL X ZJYL Jin Medical IPO Managers: Prime Number Priced at: $8.00 1M Shares
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	BMEA X BMEA Biomea Fusion Secondary Managers: JPMorgan & Citi, Oppenheimer, Barclays $30.71 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	SYT X SYT Syla Technologies IPO Managers: Boustead $8.00 1.875M Shares
Fri	No deals

View All Syndicate Announcements »

Iris Acquisition to combine with Liminatus Pharma

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access